Bacterial host strain comprising a mutant spr gene and a wild-type Tsp gene

Details for Australian Patent Application No. 2011206586 (hide)

Owner UCB Pharma S.A.

Inventors Ellis, Mark; Humphreys, David Paul

Agent Griffith Hack

Pub. Number AU-A-2011206586

PCT Pub. Number WO2011/086138

Priority 1000590.8 14.01.10 GB

Filing date 13 January 2011

Wipo publication date 21 July 2011

International Classifications

C07K 16/24 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 9/48 Enzymes, e.g. ligases (6.) - acting on peptide bonds, e.g. thromboplastin, leucine aminopeptidase (3.4)

C12N 15/70 Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

C12P 21/02 Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

Event Publications

19 July 2012 PCT application entered the National Phase

  PCT publication WO2011/086138 Priority application(s): WO2011/086138

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011206587-Bacterial host strain expressing recombinant DsbC and having reduced Tsp activity

2011206584-Bacterial host strain comprising a mutant spr gene and having reduced Tsp activity